NCT00365287View on ClinicalTrials.gov

Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

148

Participants

Timeline

Start Date

June 30, 2000

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions

Breast CancerKidney CancerLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes

Interventions

DRUG

anti-thymocyte globulin

DRUG

cyclophosphamide

DRUG

cyclosporine

DRUG

fludarabine phosphate

DRUG

mycophenolate mofetil

PROCEDURE

radiation therapy

PROCEDURE

umbilical cord blood transplantation

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Masonic Cancer Center, University of Minnesota

OTHER

NCT00365287 - Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer | Biotech Hunter | Biotech Hunter